Liver Cancer Trial, Recruiting NCT06694636 Sponsor: Zhongda Hospital Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT06694636
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer), either based on clinical assessment or confirmed by a tissue sample.
  • People whose liver cancer has spread to other parts of the body or has grown in ways that make surgical removal not possible.
  • People whose cancer has continued to grow or spread after trying two previous lines of treatment.
  • People who agree to take part in the study and sign a consent form.

Who may not be able to join:

  • People who are not considered suitable candidates for ablation surgery (a procedure that destroys tumour tissue).
  • People who are pregnant, breastfeeding, or planning to become pregnant.
  • People who experience a significant drop in blood pressure when standing up (orthostatic hypotension).
  • People whose liver cancer is a mixed type (meaning it contains more than one type of cancer cell).
  • People who have a blockage in their intestines.
  • People who have a notable tendency to bleed easily or have a blood-related condition.
  • People who have an active or severe infection throughout the body.
  • People who have had a stroke or a brief stroke-like episode (TIA) within the past two weeks.
  • People who have had a serious heart event, such as a heart attack, within the past two weeks.
  • People whom the trial investigators have assessed as not being suitable for this trial for any other reason (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gao-Jun Gao-Jun, Zhongda Hospital

Phone: +86-25-83272121

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Zhongda Hospital
Registry
ClinicalTrials.gov
Start date
1 February 2024
Est. completion
1 February 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

ORR

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov